NASDAQ:FENC
Fennec Pharmaceuticals Inc.
- Stock
Last Close
9.75
13/05 20:00
Market Cap
263.68M
Beta: 0.16
Volume Today
126.32K
Avg: 80.91K
PE Ratio
−11.72
PFCF: −16.43
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 1.84M - | -2.18M 217.94% | -659K 69.72% | -2.79M 323.22% | -7.05M 152.64% | -9.89M 40.33% | -12.78M 29.20% | -18.11M 41.75% | -17.35M 4.21% | -23.71M 36.71% | -16.34M 31.10% | |
depreciation and amortization | 64K - | 402K 528.13% | 14K 96.52% | 132K 842.86% | 221K 67.42% | |||||||
deferred income tax | -64K - | -402K 528.13% | -14K 96.52% | 7.46M - | ||||||||
stock based compensation | 87K - | 627K 620.69% | 97K 84.53% | 615K 534.02% | 1.52M 146.67% | 1.82M 20.30% | 2.67M 46.03% | 2.79M 4.73% | 3.75M 34.32% | 4.09M 9.02% | 5.35M 31.00% | |
change in working capital | -365K - | 120K 132.88% | -63K 152.50% | 10K 115.87% | 1.01M 10,030% | 132K 86.97% | 569K 331.06% | -763K 234.09% | -932K 22.15% | 1.10M 218.35% | -6.90M 725.78% | |
accounts receivables | -1.54M - | -7.40M 379.11% | ||||||||||
inventory | -576K - | -1.61M 179.34% | ||||||||||
accounts payables | -11K - | -54K 390.91% | 611K 1,231.48% | 177K 71.03% | 580K 227.68% | -41K 107.07% | -794K 1,836.59% | 1.61M 303.02% | 1.41M 12.32% | |||
other working capital | -52K - | 64K 223.08% | 402K 528.13% | -45K 111.19% | -11K 75.56% | -722K 6,463.64% | -138K 80.89% | 1.61M 1,268.12% | 695.52K 56.85% | |||
other non cash items | -3.78M - | -270K 92.85% | -1.24M 358.15% | 40K 103.23% | 875K 2,087.50% | 105K 88% | 481K 358.10% | 486K 1.04% | 307K 36.83% | 334K 8.79% | -7.25M 2,271.21% | |
net cash provided by operating activities | -2.21M - | -1.70M 23.12% | -1.86M 9.59% | -2.12M 14.07% | -3.64M 71.42% | -7.83M 114.94% | -9.06M 15.77% | -15.60M 72.13% | -14.22M 8.80% | -18.06M 26.97% | -17.46M 3.33% | |
investments in property plant and equipment | ||||||||||||
acquisitions net | ||||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | ||||||||||||
other investing activites | ||||||||||||
net cash used for investing activites | ||||||||||||
debt repayment | -4.94M - | -5M 1.17% | -5.09M 1.83% | |||||||||
common stock issued | 1.57M - | 2.18M 38.98% | 5M - | 27.38M 447.62% | 31.97M - | -7.93K 100.02% | 723.16K 9,219.79% | 1.75M 141.64% | ||||
common stock repurchased | -194K - | |||||||||||
dividends paid | -529.16K - | |||||||||||
other financing activites | 161K - | 497K 208.70% | 108K 78.27% | 594K 450% | 2.35M 295.12% | -71K 103.03% | 322K 553.52% | 9.93M 2,983.25% | 25.73M 159.18% | -79.43K 100.31% | ||
net cash used provided by financing activities | 1.57M - | 2.34M 49.24% | 497K 78.79% | 5.11M 927.77% | 27.98M 447.67% | 2.35M 91.61% | -71K 103.03% | 32.29M 45,577.46% | 4.98M 84.58% | 20.73M 316.47% | 6.76M 67.39% | |
effect of forex changes on cash | ||||||||||||
net change in cash | -640K - | 644K 200.63% | -1.36M 311.96% | 2.98M 318.61% | 24.33M 715.48% | -5.48M 122.52% | -9.13M 66.65% | 16.69M 282.83% | -9.24M 155.37% | 2.67M 128.93% | -10.56M 494.99% | |
cash at beginning of period | 2.30M - | 1.66M 27.79% | 2.31M 38.73% | 942K 59.17% | 3.93M 316.77% | 28.26M 619.82% | 22.78M 19.39% | 13.65M 40.08% | 30.34M 122.30% | 21.10M 30.46% | 23.76M 12.62% | |
cash at end of period | 1.66M - | 2.31M 38.73% | 942K 59.17% | 3.93M 316.77% | 28.26M 619.82% | 22.78M 19.39% | 13.65M 40.08% | 30.34M 122.30% | 21.10M 30.46% | 23.77M 12.67% | 13.20M 44.47% | |
operating cash flow | -2.21M - | -1.70M 23.12% | -1.86M 9.59% | -2.12M 14.07% | -3.64M 71.42% | -7.83M 114.94% | -9.06M 15.77% | -15.60M 72.13% | -14.22M 8.80% | -18.06M 26.97% | -17.46M 3.33% | |
capital expenditure | ||||||||||||
free cash flow | -2.21M - | -1.70M 23.12% | -1.86M 9.59% | -2.12M 14.07% | -3.64M 71.42% | -7.83M 114.94% | -9.06M 15.77% | -15.60M 72.13% | -14.22M 8.80% | -18.06M 26.97% | -17.46M 3.33% |
All numbers in USD (except ratios and percentages)